Aurora Cannabis Inc. (TSX:ACB) entered into a letter of intent to acquire Whistler Medical Marijuana Corporation ("Whistler") from Cronos Group Inc. and others for approximately CAD 160 million on January 14, 2019. Aurora Cannabis Inc. entered into a definitive agreement to acquire Whistler Medical Marijuana Corporation on January 31, 2019. The purchase consideration will be paid in the form of Aurora stock and includes certain milestone payments in relation to Whistler achieving certain operational objectives. Christopher Pelz, Chief Executive Officer and Founder of Whistler, and his team will join Aurora pursuant to the deal.

Closing of the transaction is subject to customary closing conditions, including execution of definitive documentation, completion of satisfactory due diligence, receipt of approval of the shareholders of Whistler, and receipt of applicable third party and regulatory approvals and the satisfaction of other conditions customary in transactions of this nature. Stoic Advisory Inc. acted as financial advisor and Norton Rose Fulbright Canada LLP acted as legal advisor to Whistler. McMillan LLP served as legal counsel to Aurora.